Stay updated on Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.

Latest updates to the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page
- Check2 days agoChange DetectedExpanded the study locations with numerous new site entries across US states and international regions (e.g., New South Wales, Ontario, Greater London) and removed certain existing location entries as part of revision 3.3.3.SummaryDifference2%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedMinor textual updates to the PubMed publications display (auto-fill note) and to revision/version labels (v3.3.2, v3.2.0), with no impact on the study content or user tasks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedAdministrative notice about government funding status and operating updates was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check59 days agoChange DetectedMinor UI/layout adjustments to the Study Details page (spacing and section arrangement) with no changes to core content such as conditions, interventions, outcomes, or eligibility criteria.SummaryDifference0.3%

- Check81 days agoChange DetectedAdds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference2%

- Check88 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.